93 related articles for article (PubMed ID: 24458845)
1. Timing of oral contraceptive use and the risk of breast cancer in BRCA1 mutation carriers.
Kotsopoulos J; Lubinski J; Moller P; Lynch HT; Singer CF; Eng C; Neuhausen SL; Karlan B; Kim-Sing C; Huzarski T; Gronwald J; McCuaig J; Senter L; Tung N; Ghadirian P; Eisen A; Gilchrist D; Blum JL; Zakalik D; Pal T; Sun P; Narod SA;
Breast Cancer Res Treat; 2014 Feb; 143(3):579-86. PubMed ID: 24458845
[TBL] [Abstract][Full Text] [Related]
2. Changes in body weight and the risk of breast cancer in BRCA1 and BRCA2 mutation carriers.
Kotsopoulos J; Olopado OI; Ghadirian P; Lubinski J; Lynch HT; Isaacs C; Weber B; Kim-Sing C; Ainsworth P; Foulkes WD; Eisen A; Sun P; Narod SA
Breast Cancer Res; 2005; 7(5):R833-43. PubMed ID: 16168130
[TBL] [Abstract][Full Text] [Related]
3. Smoking and the risk of breast cancer in BRCA1 and BRCA2 carriers: an update.
Ginsburg O; Ghadirian P; Lubinski J; Cybulski C; Lynch H; Neuhausen S; Kim-Sing C; Robson M; Domchek S; Isaacs C; Klijn J; Armel S; Foulkes WD; Tung N; Moller P; Sun P; Narod SA;
Breast Cancer Res Treat; 2009 Mar; 114(1):127-35. PubMed ID: 18483851
[TBL] [Abstract][Full Text] [Related]
4. Oral Contraceptive and Breast Cancer Risks: a Case Control Study in Six Referral Hospitals in Indonesia.
Wahidin M; Djuwita R; Adisasmita A
Asian Pac J Cancer Prev; 2018 Aug; 19(8):2199-2203. PubMed ID: 30139225
[TBL] [Abstract][Full Text] [Related]
5. Serum selenium level and other risk factors for breast cancer among patients in a Malaysian hospital.
Rejali L; Jaafar MH; Ismail NH
Environ Health Prev Med; 2007 May; 12(3):105-10. PubMed ID: 21432063
[TBL] [Abstract][Full Text] [Related]
6. Modifiers of cancer risk in BRCA1 and BRCA2 mutation carriers: systematic review and meta-analysis.
Friebel TM; Domchek SM; Rebbeck TR
J Natl Cancer Inst; 2014 Jun; 106(6):dju091. PubMed ID: 24824314
[TBL] [Abstract][Full Text] [Related]
7. Recent oral contraceptive use by formulation and breast cancer risk among women 20 to 49 years of age.
Beaber EF; Buist DS; Barlow WE; Malone KE; Reed SD; Li CI
Cancer Res; 2014 Aug; 74(15):4078-89. PubMed ID: 25085875
[TBL] [Abstract][Full Text] [Related]
8. Risk-benefit assessment of the combined oral contraceptive pill in women with a family history of female cancer.
Davidson BA; Moorman PG
Expert Opin Drug Saf; 2014 Oct; 13(10):1375-82. PubMed ID: 25146351
[TBL] [Abstract][Full Text] [Related]
9. Gene panel testing for inherited cancer risk.
Hall MJ; Forman AD; Pilarski R; Wiesner G; Giri VN
J Natl Compr Canc Netw; 2014 Sep; 12(9):1339-46. PubMed ID: 25190699
[TBL] [Abstract][Full Text] [Related]
10. Use of panel tests in place of single gene tests in the cancer genetics clinic.
Yorczyk A; Robinson LS; Ross TS
Clin Genet; 2015 Sep; 88(3):278-82. PubMed ID: 25318351
[TBL] [Abstract][Full Text] [Related]
11. Use of risk-reducing surgeries in a prospective cohort of 1,499 BRCA1 and BRCA2 mutation carriers.
Chai X; Friebel TM; Singer CF; Evans DG; Lynch HT; Isaacs C; Garber JE; Neuhausen SL; Matloff E; Eeles R; Tung N; Weitzel JN; Couch FJ; Hulick PJ; Ganz PA; Daly MB; Olopade OI; Tomlinson G; Blum JL; Domchek SM; Chen J; Rebbeck TR
Breast Cancer Res Treat; 2014 Nov; 148(2):397-406. PubMed ID: 25311111
[TBL] [Abstract][Full Text] [Related]
12. BRCA1 and BRCA2 mutations and the risk for colorectal cancer.
Sopik V; Phelan C; Cybulski C; Narod SA
Clin Genet; 2015 May; 87(5):411-8. PubMed ID: 25195694
[TBL] [Abstract][Full Text] [Related]
13. Targeted prostate cancer screening in BRCA1 and BRCA2 mutation carriers: results from the initial screening round of the IMPACT study.
Bancroft EK; Page EC; Castro E; Lilja H; Vickers A; Sjoberg D; Assel M; Foster CS; Mitchell G; Drew K; Mæhle L; Axcrona K; Evans DG; Bulman B; Eccles D; McBride D; van Asperen C; Vasen H; Kiemeney LA; Ringelberg J; Cybulski C; Wokolorczyk D; Selkirk C; Hulick PJ; Bojesen A; Skytte AB; Lam J; Taylor L; Oldenburg R; Cremers R; Verhaegh G; van Zelst-Stams WA; Oosterwijk JC; Blanco I; Salinas M; Cook J; Rosario DJ; Buys S; Conner T; Ausems MG; Ong KR; Hoffman J; Domchek S; Powers J; Teixeira MR; Maia S; Foulkes WD; Taherian N; Ruijs M; Helderman-van den Enden AT; Izatt L; Davidson R; Adank MA; Walker L; Schmutzler R; Tucker K; Kirk J; Hodgson S; Harris M; Douglas F; Lindeman GJ; Zgajnar J; Tischkowitz M; Clowes VE; Susman R; Ramón y Cajal T; Patcher N; Gadea N; Spigelman A; van Os T; Liljegren A; Side L; Brewer C; Brady AF; Donaldson A; Stefansdottir V; Friedman E; Chen-Shtoyerman R; Amor DJ; Copakova L; Barwell J; Giri VN; Murthy V; Nicolai N; Teo SH; Greenhalgh L; Strom S; Henderson A; McGrath J; Gallagher D; Aaronson N; Ardern-Jones A; Bangma C; Dearnaley D; Costello P; Eyfjord J; Rothwell J; Falconer A; Gronberg H; Hamdy FC; Johannsson O; Khoo V; Kote-Jarai Z; Lubinski J; Axcrona U; Melia J; McKinley J; Mitra AV; Moynihan C; Rennert G; Suri M; Wilson P; Killick E; ; Moss S; Eeles RA
Eur Urol; 2014 Sep; 66(3):489-99. PubMed ID: 24484606
[TBL] [Abstract][Full Text] [Related]
14. Society of Gynecologic Oncology statement on risk assessment for inherited gynecologic cancer predispositions.
Lancaster JM; Powell CB; Chen LM; Richardson DL;
Gynecol Oncol; 2015 Jan; 136(1):3-7. PubMed ID: 25238946
[TBL] [Abstract][Full Text] [Related]
15. The histomorphology of Lynch syndrome-associated ovarian carcinomas: toward a subtype-specific screening strategy.
Chui MH; Ryan P; Radigan J; Ferguson SE; Pollett A; Aronson M; Semotiuk K; Holter S; Sy K; Kwon JS; Soma A; Singh N; Gallinger S; Shaw P; Arseneau J; Foulkes WD; Gilks CB; Clarke BA
Am J Surg Pathol; 2014 Sep; 38(9):1173-81. PubMed ID: 25025451
[TBL] [Abstract][Full Text] [Related]
16. Oral contraceptives and breast cancer risk overall and by molecular subtype among young women.
Beaber EF; Malone KE; Tang MT; Barlow WE; Porter PL; Daling JR; Li CI
Cancer Epidemiol Biomarkers Prev; 2014 May; 23(5):755-64. PubMed ID: 24633144
[TBL] [Abstract][Full Text] [Related]
17. Progestin-only and combined oral contraceptives and receptor-defined premenopausal breast cancer risk: The Norwegian Women and Cancer Study.
Busund M; Bugge NS; Braaten T; Waaseth M; Rylander C; Lund E
Int J Cancer; 2018 Jun; 142(11):2293-2302. PubMed ID: 29349773
[TBL] [Abstract][Full Text] [Related]
18. Bilateral Oophorectomy and Breast Cancer Risk in BRCA1 and BRCA2 Mutation Carriers.
Kotsopoulos J; Huzarski T; Gronwald J; Singer CF; Moller P; Lynch HT; Armel S; Karlan B; Foulkes WD; Neuhausen SL; Senter L; Tung N; Weitzel JN; Eisen A; Metcalfe K; Eng C; Pal T; Evans G; Sun P; Lubinski J; Narod SA;
J Natl Cancer Inst; 2017 Jan; 109(1):. PubMed ID: 27601060
[TBL] [Abstract][Full Text] [Related]
19. Progestin and breast cancer risk: a systematic review.
Samson M; Porter N; Orekoya O; Hebert JR; Adams SA; Bennett CL; Steck SE
Breast Cancer Res Treat; 2016 Jan; 155(1):3-12. PubMed ID: 26700034
[TBL] [Abstract][Full Text] [Related]
20. Clinical Inquiry: do oral contraceptives put women with a family history of breast cancer at increased risk?
Freund R; Kelsberg G; Safranek S
J Fam Pract; 2014 Sep; 63(9):540, 549. PubMed ID: 25353033
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
